These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 990039)

  • 21. Effect of serum separator tubes on serum quinidine concentration measurements.
    Mauro LS; Mauro VF
    Clin Pharm; 1990 Apr; 9(4):292-4. PubMed ID: 2331844
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood collection technique: no effect on in vitro protein binding of prednisolone.
    Rocci ML; Jusko WJ
    J Pharm Sci; 1981 Oct; 70(10):1160-1. PubMed ID: 7299653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.
    Chien YW; Lambert HJ; Karim A
    J Pharm Sci; 1974 Dec; 63(12):1877-9. PubMed ID: 4449018
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact.
    De Smet R; Van Kaer J; Liebich H; Lesaffer G; Verstraete A; Dhondt A; Duym P; Lameire N; Vanholder R
    Clin Chem; 2001 May; 47(5):901-9. PubMed ID: 11325895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated phenytoin concentration caused by sampling through the drug-administration catheter.
    Murphy JE; Ward ES
    Pharmacotherapy; 1991; 11(4):348-50. PubMed ID: 1923919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four fluorescence polarization immunoassays for therapeutic drug monitoring evaluated.
    Haver VM; Audino N; Burris S; Nelson M
    Clin Chem; 1989 Jan; 35(1):138-40. PubMed ID: 2463117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 30. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.
    Pérez-Mateo M; Erill S
    Eur J Clin Pharmacol; 1977 Mar; 11(3):225-31. PubMed ID: 856605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma concentrations of antiarrhythmic drugs (author's transl)].
    Kasanuki H; Hirosawa K
    Kokyu To Junkan; 1977 May; 25(5):383-91. PubMed ID: 560038
    [No Abstract]   [Full Text] [Related]  

  • 32. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An HPLC method for the quantitation of quinidine and its metabolites in plasma: an application to a quinidine-phenytoin drug interaction study.
    Pershing LK; Peat MA; Finkle BS
    J Anal Toxicol; 1982; 6(3):153-6. PubMed ID: 7109560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical use of blood levels of cardiac drugs.
    Atkinson AJ
    Mod Concepts Cardiovasc Dis; 1973 Jan; 42(1):1-4. PubMed ID: 4682595
    [No Abstract]   [Full Text] [Related]  

  • 35. The influence of blood collection technique on serum and plasma protein binding of disopyramide.
    Haughey DB; Lima JJ
    Eur J Clin Pharmacol; 1982; 22(2):185-9. PubMed ID: 7094989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of certain drugs on the plasma protein binding of phenytoin.
    Hooper WD; Sutherland JM; Bochner F; Tyrer JH; Eadie MJ
    Aust N Z J Med; 1973 Aug; 3(4):377-81. PubMed ID: 4148548
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenytoin assay on dried blood spots.
    Coombes EJ
    Neurology; 1984 May; 34(5):703-4. PubMed ID: 6538671
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetic and clinical implications of quinidine protein binding.
    Woo E; Greenblatt DJ
    J Pharm Sci; 1979 Apr; 68(4):466-70. PubMed ID: 438971
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.
    Nilsen OG; Storstein L; Jacobsen S
    Biochem Pharmacol; 1977 Feb; 26(3):229-35. PubMed ID: 843392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.